Snyder Capital Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$98.4M Sell
1,882,298
-44,568
-2% -$2.68M 1.91% 15
2025
Q4
$113M Buy
1,926,866
+207,731
+12% +$12.6M 2.11% 15
2025
Q3
$95.6M Buy
1,719,135
+384,694
+29% +$20.6M 1.81% 16
2025
Q2
$68.7M Buy
1,334,441
+107,865
+9% +$5.42M 1.46% 25
2025
Q1
$71.9M Buy
1,226,576
+99,196
+9% +$6.72M 1.57% 25
2024
Q4
$81.2M Buy
1,127,380
+63,590
+6% +$4.67M 1.7% 22
2024
Q3
$85M Buy
1,063,790
+60,099
+6% +$4.52M 1.77% 20
2024
Q2
$71.9M Sell
1,003,691
-18,929
-2% -$1.39M 1.61% 21
2024
Q1
$72M Buy
1,022,620
+57,660
+6% +$4.13M 1.54% 26
2023
Q4
$74.5M Buy
964,960
+838,128
+661% +$55.2M 1.68% 21
2023
Q3
$8.63M Sell
126,832
-380
-0.3% -$30K 0.19% 70
2023
Q2
$10.4M Buy
127,212
+7,058
+6% +$567K 0.22% 69
2023
Q1
$8.91M Sell
120,154
-2,862
-2% -$221K 0.19% 71
2022
Q4
$10.2M Sell
123,016
-1,872
-1% -$149K 0.23% 72
2022
Q3
$8.87M Sell
124,888
-2,860
-2% -$247K 0.23% 71
2022
Q2
$11.1M Buy
127,748
+34,416
+37% +$3.23M 0.3% 70
2022
Q1
$10.1M Sell
93,332
-2,648
-3% -$273K 0.26% 73
2021
Q4
$12.4M Sell
95,980
-25,896
-21% -$3.17M 0.3% 73
2021
Q3
$14.8M Sell
121,876
-4,996
-4% -$608K 0.39% 70
2021
Q2
$14.3M Sell
126,872
-65,300
-34% -$6.87M 0.4% 66
2021
Q1
$18.3M Sell
192,172
-16,228
-8% -$1.48M 0.53% 60
2020
Q4
$16.5M Sell
208,400
-1,484
-0.7% -$107K 0.54% 59
2020
Q3
$13M Buy
209,884
+26,136
+14% +$1.7M 0.56% 57
2020
Q2
$12.1M Sell
183,748
-720
-0.4% -$43.1K 0.55% 55
2020
Q1
$8.74M Buy
184,468
+45,124
+32% +$2.26M 0.5% 58
2019
Q4
$7.65M Buy
139,344
+32,576
+31% +$1.71M 0.3% 65
2019
Q3
$5.22M Sell
106,768
-272
-0.3% -$13.6K 0.23% 66
2019
Q2
$5.58M Sell
107,040
-2,204
-2% -$111K 0.25% 65
2019
Q1
$5.42M Sell
109,244
-12,684
-10% -$571K 0.26% 65
2018
Q4
$4.41M Buy
121,928
+12,304
+11% +$514K 0.24% 63
2018
Q3
$5.59M Sell
109,624
-20,104
-15% -$890K 0.25% 62
2018
Q2
$4.8M Buy
129,728
+8,756
+7% +$334K 0.23% 61
2018
Q1
$4.57M Buy
120,972
+34,888
+41% +$1.23M 0.23% 60
2017
Q4
$2.79M Buy
86,084
+5,096
+6% +$162K 0.14% 65
2017
Q3
$2.45M Sell
80,988
-12,948
-14% -$384K 0.12% 65
2017
Q2
$2.76M Buy
93,936
+5,008
+6% +$137K 0.15% 62
2017
Q1
$2.26M Buy
88,928
+39,120
+79% +$1.01M 0.12% 66
2016
Q4
$1.28M Sell
49,808
-2,660
-5% -$69.9K 0.08% 65
2016
Q3
$1.44M Sell
52,468
-18,860
-26% -$518K 0.09% 67
2016
Q2
$2.01M Sell
71,328
-10,572
-13% -$272K 0.13% 68
2016
Q1
$1.94M Buy
81,900
+23,616
+41% +$520K 0.13% 65
2015
Q4
$1.31M Hold
58,284
0.09% 66
2015
Q3
$1.35M Sell
58,284
-77,748
-57% -$1.95M 0.09% 69
2015
Q2
$3.35M Sell
136,032
-54,528
-29% -$1.36M 0.19% 57
2015
Q1
$4.78M Sell
190,560
-3,700
-2% -$88K 0.24% 56
2014
Q4
$4.49M Sell
194,260
-29,920
-13% -$685K 0.24% 55
2014
Q3
$5.24M Sell
224,180
-89,920
-29% -$2.11M 0.29% 52
2014
Q2
$7.27M Sell
314,100
-880
-0.3% -$19.4K 0.34% 54
2014
Q1
$6.72M Hold
314,980
0.35% 53
2013
Q4
$7.46M Sell
314,980
-26,800
-8% -$581K 0.37% 54
2013
Q3
$6.84M Sell
341,780
-127,360
-27% -$2.42M 0.35% 52
2013
Q2
$8.1M Buy
+469,140
New +$7.79M 0.43% 53

Other funds holding TECH

Snyder Capital Management's TECH Position: Q1 2026 in Review

Snyder Capital Management reduced its Bio-Techne (TECH) stake by 2.3% in Q1 2026, selling an estimated $2.68M and leaving 1,882,298 shares worth $98.4M. The position accounts for 1.91% of the portfolio, ranked #15.

Snyder Capital Management first reported a position in TECH in Q2 2013 and has held it in 52 quarters since. The position peaked at $113M in Q4 2025. 584 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Snyder Capital Management held 1,882,298 shares of Bio-Techne worth $98.4M as of Q1 2026.
  • Snyder Capital Management sold 44,568 Bio-Techne shares in Q1 2026, an estimated $2.68M.
  • Bio-Techne made up 1.91% of Snyder Capital Management's portfolio in Q1 2026, its #15 holding.
  • Snyder Capital Management first reported a position in Bio-Techne in Q2 2013 and has held it in 52 quarters since.
  • Snyder Capital Management's Bio-Techne position peaked at $113M in Q4 2025.
  • 584 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Snyder Capital Management's 13F filing for Q1 2026, filed 14 May 2026.